Matrix Asset Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-50,000
| Closed | -$314K | – | 81 |
|
|
2020
Q2 | $314K | Hold |
50,000
| – | – | 0.06% | 63 |
|
|
2020
Q1 | $92K | Hold |
50,000
| – | – | 0.02% | 68 |
|
|
2019
Q4 | $169K | Sell |
50,000
-10,000
| -17% | -$23.8K | 0.03% | 74 |
|
|
2019
Q3 | $128K | Hold |
60,000
| – | – | 0.02% | 72 |
|
|
2019
Q2 | $160K | Hold |
60,000
| – | – | 0.03% | 65 |
|
|
2019
Q1 | $285K | Hold |
60,000
| – | – | 0.05% | 63 |
|
|
2018
Q4 | $144K | Hold |
60,000
| – | – | 0.03% | 65 |
|
|
2018
Q3 | $264K | Hold |
60,000
| – | – | 0.04% | 60 |
|
|
2018
Q2 | $432K | Buy |
60,000
+10,000
| +20% | +$68K | 0.07% | 54 |
|
|
2018
Q1 | $258K | Sell |
50,000
-22,000
| -31% | -$157K | 0.04% | 61 |
|
|
2017
Q4 | $274K | Hold |
72,000
| – | – | 0.04% | 60 |
|
|
2017
Q3 | $122K | Hold |
72,000
| – | – | 0.02% | 63 |
|
|
2017
Q2 | $144K | Buy |
72,000
+50,000
| +227% | +$97.6K | 0.02% | 64 |
|
|
2017
Q1 | $87K | Hold |
22,000
| – | – | 0.02% | 63 |
|
|
2016
Q4 | $108K | Sell |
22,000
-1,128
| -5% | -$6.78K | 0.02% | 71 |
|
|
2016
Q3 | $179K | Hold |
23,128
| – | – | 0.03% | 73 |
|
|
2016
Q2 | $130K | Hold |
23,128
| – | – | 0.03% | 69 |
|
|
2016
Q1 | $124K | Hold |
23,128
| – | – | 0.02% | 69 |
|
|
2015
Q4 | $201K | Hold |
23,128
| – | – | 0.04% | 73 |
|
|
2015
Q3 | $194K | Hold |
23,128
| – | – | 0.03% | 64 |
|
|
2015
Q2 | $408K | Hold |
23,128
| – | – | 0.05% | 60 |
|
|
2015
Q1 | $267K | Hold |
23,128
| – | – | 0.03% | 68 |
|
|
2014
Q4 | $233K | Hold |
23,128
| – | – | 0.03% | 70 |
|
|
2014
Q3 | $105K | Hold |
23,128
| – | – | 0.01% | 72 |
|
|
2014
Q2 | $156K | Hold |
23,128
| – | – | 0.02% | 70 |
|
|
2014
Q1 | $297K | Hold |
23,128
| – | – | 0.04% | 63 |
|
|
2013
Q4 | $187K | Buy |
+23,128
| New | +$204K | 0.02% | 68 |
|
Other funds holding SRNE
CAM
N